alexa Free-pharmacogenomics-journal|OMICS International|Journal Of Pharmacogenomics And Pharmacoproteomics

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Free Pharmacogenomics Journal

The incorporation of pharmacogenetic/pharmacogenomic protocols to Adverse Drug (AD) research and clinical practice can foster therapeutics optimization by helping to develop cost-effective pharmaceuticals and improving drug efficacy and safety. The main aim of a cost-effective treatment is to halt disease progression via a modification of the functional cascade involving AD genomics, transcriptomics, proteomics and metabolomics. Jerzy Leszek, Pharmacogenomics of Alziemer’s Disease.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on October, 2020